Unexpected severe effects or treatment failure need prompt help
Call emergency services for collapse, severe breathing difficulty, seizure, major bleeding, profound drowsiness, or another life-threatening reaction after using any medicine. If a product may be counterfeit, contaminated, the wrong strength, or damaged, do not use more until a licensed pharmacist or regulator verifies it. For an essential medicine, arrange an urgent legitimate replacement plan rather than simply missing doses.
An approved generic medicine is not a fake brand. It has the same active ingredient, strength, dosage form, and route as its reference medicine and must demonstrate comparable delivery in the body. Counterfeit or falsified products are different: they deliberately misrepresent identity, composition, or source. The greatest online risk is not “generic versus brand,” but licensed supply chain versus an unverified seller.
Key points
- Approved generics must meet regulator standards for quality and bioequivalence.
- Color, shape, coating, flavor, and other inactive ingredients may differ.
- A biosimilar and a compounded medicine are not types of ordinary generic.
- Verify the exact pharmacy website in the national regulator’s register before paying or uploading a prescription.
- No prescription, no pharmacist, miracle claims, social-media sales, and extreme discounts are major warning signs.
What an approved generic has in common
FDA defines a generic as an approved version of a brand or reference drug with the same active ingredient, strength, dosage form, route of administration, and intended conditions of use, with limited labeling differences. The manufacturer must demonstrate pharmaceutical equivalence, bioequivalence, consistent manufacturing, stability, purity, and quality.
Bioequivalence means that the active ingredient becomes available at a similar rate and extent. It does not mean every tablet in every person produces an identical blood curve. Regulators set scientific limits so any observed difference is not expected to change clinical effect or safety.
A generic application relies on the regulator’s previous finding that the reference medicine is safe and effective; it does not repeat every original clinical trial. That abbreviated pathway and market competition reduce development cost. Lower price is not evidence of weaker medicine.
Why the tablet can look different
Trademark rules and manufacturing choices mean a generic may have a different color, shape, imprint, coating, flavor, or packaging. Inactive ingredients—fillers, binders, dyes, preservatives, and flavorings—may differ while the active ingredient remains the same.
Most inactive differences are not clinically important. A minority of people may react to an excipient or notice a tolerability difference. Lactose, gluten sources, dyes, alcohol, sugars, sodium, and animal-derived ingredients can matter for selected allergies, intolerances, medical conditions, or beliefs. Ask the pharmacist to compare current official ingredient lists rather than assuming the active drug is the cause.
A different appearance can also create confusion and double-dosing. Before taking an unfamiliar tablet, compare the dispensing label, generic name, strength, formulation, and imprint, then confirm with the dispensing pharmacy. Do not identify a pill from color alone.
Not every same-name product is substitutable
Immediate-release and modified-, delayed-, or extended-release formulations are not interchangeable unless the prescription and regulator say so. Tablets, liquids, patches, inhalers, injections, and device combinations deliver medicine differently. Different salts or esters can also represent different approved products.
Approved therapeutically equivalent generics are expected to produce the same clinical result. For selected medicines with tight therapeutic monitoring, complex delivery, or device technique, a clinician may want consistent supply or testing after any manufacturer switch. That does not mean approved generics are inferior; it means small clinical changes or handling differences matter enough to monitor.
Biosimilar is not generic
Biologic medicines are large, complex products made using living systems and cannot be copied like a simple chemical molecule. A biosimilar must be highly similar to an approved reference biologic with no clinically meaningful differences in safety, purity, or potency.
All FDA-approved biosimilars meet that standard. “Interchangeable” is an additional U.S. designation related to pharmacy substitution under state law; lack of that designation does not mean a biosimilar is lower quality. Other countries use different substitution systems.
Compounded does not mean generic
Compounding combines or alters ingredients for an individual need, such as removing an allergenic dye or creating a suitable liquid when no approved product fits. In the United States, compounded medicines are not FDA-approved, and FDA does not verify their safety, effectiveness, or quality before marketing.
A compounded product can meet a legitimate clinical need, but it should not be advertised as an approved generic, identical copy, or regulator-approved alternative. Poor practices can produce contamination or too much or too little active ingredient. Ask why an approved product cannot meet the need, who compounds it, and what testing and oversight apply locally.
Substandard, falsified, and unapproved
WHO calls a product substandard when an authorized medicine fails quality standards or specifications, often because of manufacturing or control failures. A falsified product deliberately misrepresents its identity, composition, or source. An unapproved product lacks authorization for that market; it is not automatically falsified, but its quality, effectiveness, or labeling may not have been evaluated.
Falsified products may contain no active ingredient, the wrong ingredient, an unsafe contaminant, or too much or too little medicine. They can also be genuine product diverted, expired, relabeled, or damaged by heat or freezing. Treatment failure can be as dangerous as direct poisoning, especially for infection, diabetes, seizures, anticoagulation, cancer, or transplant care.
Why a polished website proves nothing
Illegal sellers copy pharmacy branding, national flags, regulator seals, reviews, and photos of real pharmacists. A padlock or HTTPS protects the connection; it does not license the seller. Search ads and social-media verification marks also do not establish pharmacy authorization.
Red flags include offering prescription medicine without a valid prescription or adequate clinical assessment; no physical address or licensed pharmacist; a domain absent from the official register; worldwide shipping that ignores local law; prices far below the normal range; “no side effects” or miracle claims; crypto-only payment; pressure countdowns; and medicine shipped loose, damaged, expired, unsealed, or in an unexplained foreign-language package.
The safe verification method
- Start outside the seller’s website. Open your national medicines or pharmacy regulator through a known government address or trusted search result.
- Find its official pharmacy register. Search the exact legal business and website domain, not just a similar name.
- Match the details. Confirm physical address, telephone, licence status, pharmacy owner, and domain.
- Confirm professional access. A licensed pharmacist should be available for medicine and interaction questions.
- Check prescription rules. The site should require a valid prescription when local law does.
- Review security and terms. Check privacy, payment, recurring subscription, delivery, cold-chain, return, and complaint policies.
- Stop if anything conflicts. A badge that does not lead to the regulator’s matching entry is not proof.
How verification differs by region
In the United States, FDA’s BeSafeRx directs users to state boards of pharmacy; the pharmacy should be licensed where it operates and serves the patient. In the European Union, a registered retailer displays the common logo. Click it and confirm that the exact domain appears on the national authority’s register—the logo image alone can be copied.
The United Kingdom has an MHRA register of authorized online medicine sellers and separate pharmacy-professional registration. Since 2021, the EU distance-selling logo applies only in Northern Ireland, not England, Scotland, or Wales. Canada regulates pharmacies through provinces and territories; the listed physical pharmacy and pharmacist should match the relevant authority’s record.
Elsewhere, use the national medicines regulator or health ministry. If no reliable public register exists, obtain medicine through an established local licensed pharmacy or health service rather than trusting an international badge.
Check the delivery before the first dose
Compare the name, active ingredient, strength, dosage form, quantity, prescriber directions, manufacturer, batch or lot, expiry, seals, and storage instructions with the order. Look for spelling errors, inconsistent fonts, poor print, altered labels, broken blisters, discoloration, powder, moisture, or tablets of mixed appearance.
Temperature-sensitive medicine needs documented cold-chain delivery and an acceptable arrival temperature. A cold pack that has melted does not prove the product is unusable or safe; ask the dispensing pharmacy using the manufacturer’s stability information.
If the appearance changed after a legitimate refill, call the pharmacy before assuming counterfeit. Manufacturers and authorized generics can change. If the pharmacy cannot verify the batch or source, preserve the package, receipt, shipping materials, and photos for the regulator.
Unexpected response after a switch
New symptoms can come from the underlying illness, dose error, interaction, excipient, adherence change, expectation, or a quality problem. Record the manufacturer, imprint, lot, start date, doses, symptoms, and other changes. Do not compensate by taking extra medicine.
Contact the pharmacist and prescriber promptly. They can verify therapeutic equivalence, check interactions and recalls, compare inactive ingredients, order monitoring when appropriate, and report a suspected quality problem. A detailed single report can help a regulator investigate.
Privacy and financial safety
Pharmacy sites collect sensitive diagnoses, identity documents, prescriptions, addresses, and payment data. Read whether information is sold or used for advertising, whether a subscription renews automatically, and how to cancel. Unexpected charges, requests for gift cards, off-platform messaging, or a demand for remote access to your device are fraud warnings.
Do not send a prescription through an unverified social-media account or messaging channel. Report suspected illegal sales, counterfeit products, privacy abuse, and adverse effects to the relevant national regulator and payment provider.
Questions people often ask
Are generic medicines weaker?
No. An approved generic has the same active ingredient and strength and must demonstrate bioequivalence and manufacturing quality.
Why did my pill change color?
The pharmacy may have dispensed another approved manufacturer with different inactive ingredients. Confirm the label, imprint, and strength with the pharmacist before use.
Is a compounded copy a generic?
No. A generic is regulator-approved through a defined equivalence pathway. A compounded medicine follows a different system and may be appropriate only for a specific clinical need.
Does an official-looking pharmacy logo prove the site is safe?
No. Start on the regulator’s own register and verify the exact domain and licence details; copied logos and fake storefronts are common.
Sources and evidence scope
This guide was researched using 2026 FDA information on generic medicines, biosimilars, compounding, online-pharmacy safety, and counterfeits; WHO’s global definitions; EMA’s EU verification guidance; the UK MHRA seller register; and Health Canada’s online-buying guidance. Sources were checked on August 21, 2026. Licences, logos, substitution rules, import restrictions, and reporting routes vary by country and can change quickly.